NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

NRC HEALTH

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$20.47+0.32 (+1.59%)

Close on Oct 19, 2026

Market cap: $450.52M
P/E (TTM): 0.4
Dividend yield: 2.54%

NRC HEALTH income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	137	143	149	152	148	133	128	120	118	109	102	99	93	86	76	63	58
Selling, General & Admin	55	45	47	43	39	34	33	31	30	28	27	25	25	24	23	20	16
Operating Expenses	–	–	–	–	–	–	–	84	83	78	76	71	68	64	57	50	44
Total Costs & Expenses	115	108	109	105	98	91	85	84	83	–	–	–	–	–	–	–	–
Operating Income	23	35	40	47	50	43	43	35	34	31	26	28	25	23	19	14	14
Interest Expense	4.76	2.60	0.86	1.21	1.67	1.81	2.09	1.51	0.08	0.19	0.22	0.31	0.40	0.54	0.63	0.49	0.41
Interest & Investment Income	0.11	0.13	0.82	0.17	0.01	0.02	0.04	0.06	0.10	0.05	0.06	0.08	0.06	0.03	0.01	0.01	0.00
Other Non-Operating Income	-4.75	-2.50	-0.08	-3.73	-1.65	-1.21	-2.52	-0.57	0.06	0.16	0.91	-0.20	-0.32	-0.51	-0.58	-0.54	-0.58
Asset Impairment Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	–	–	–
Gain (Loss) on Sale of Assets	-0.06	-0.02	0	-0.01	-0.01	-0.01	0.01	-0.19	-0.03	-0.02	1.10	0.00	-0.02	0.00	0.00	0.00	0.00
Pretax Income	18	33	40	43	49	41	41	35	34	31	27	28	24	22	18	13	13
Income Tax Expense	6.25	7.91	8.99	11	11	4.21	8.11	4.66	11	11	9.75	9.94	9.00	7.14	6.60	4.82	4.63
Net Income incl. Noncontrolling Interests	12	25	31	32	37	37	32	30	23	21	–	–	15	15	12	8.50	8.49
Net Income	–	–	–	–	–	–	–	30	23	21	18	18	15	15	12	12	8.49
Net Income to Common	11	25	31	32	37	37	–	–	–	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	50.00	1.05	1.26	1.28	1.47	1.48	1.30	–	–	–	–	–	–	2.22	1.73	1.28	1.28
EPS (Diluted)(per share)	50.00	1.04	1.25	1.27	1.46	1.45	1.26	–	–	–	–	–	–	2.17	1.69	1.26	1.26
Shares Outstanding (Basic, Weighted)(shares)	22	24	25	25	25	25	25	–	–	–	–	–	–	6.78	6.67	6.64	6.64
Shares Outstanding (Diluted, Weighted)(shares)	22	24	25	25	26	26	26	–	–	–	–	–	–	6.95	6.84	6.74	6.72
Dividend per Share(per share)	0.52	0.48	1.48	0.84	0.48	0.21	0.78	–	–	–	–	–	–	2.54	0.88	0.76	0.64
EBITDA	30	41	46	–	–	–	49	41	39	35	31	32	29	27	24	19	18

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: 10.5%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 0.65
Debt to equity: 13.75
Debt to assets: 66.1%
Cash to current liabilities: 9.5%

Valuation

P/E ratio: 0.4
Price to sales: 3.22
Price to book: 68.79
Dividend yield: 2.54%